Woodline Partners LP

Position in WVE — Wave Life Sciences, Inc.

CIK 1784547 San Francisco, CA

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,036,585

-$504,764 QoQ

Shares Held

350,531

0.0% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#62

of 237 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. WVE ranks #169 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,036,585	350,531	0.0%	Shares	Sole	2026-08-14
2026-03-31	$2,541,349	350,531	0.0%	Shares	Sole	2026-05-15
2025-12-31	$5,959,027	350,531	-22.5%	Shares	Sole	2026-02-17
2025-06-30	$2,938,390	452,060	0.0%	Shares	Sole	2025-08-14
2025-03-31	$3,652,644	452,060	+0.1%	Shares	Sole	2025-05-15
2024-12-31	$5,588,926	451,813	0.0%	Shares	Sole	2025-02-14
2024-09-30	$3,704,866	451,813	-52.4%	Shares	Sole	2024-11-14
2024-03-31	$5,851,899	948,444	-31.8%	Shares	Sole	2024-05-15
2023-12-31	$7,027,383	1,391,561	+13.3%	Shares	Sole	2024-02-14
2023-09-30	$7,064,927	1,228,683	+140.5%	Shares	Sole	2023-11-14
2023-03-31	$2,212,188	510,898	+46.2%	Shares	Sole	2023-05-15
2022-12-31	$2,446,388	349,484	-28.3%	Shares	Sole	2023-02-14
2022-09-30	$1,758,842	487,214	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.